Taken together, it appears that modulating the Nogo-A signaling pathway and the downstream LINGO-1 activity may prevent AD pathology and simultaneously encourage OPC proliferation, possibly enhancing remyelination. This evidence concerns the gene LINGO1 and Alzheimer disease.